Searched for
IVF COMPANY LISTING
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...- PE wars to billion-dollar IPO dreams, hospital sector is fighting fitMajor private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...
- IPO investors brace for 70 lock-in expiries worth $35 billion in three months. Do you own any?According to Nuvama Alternative & Quantitative Research, the Indian stock market is set to witness a significant wave of lock-in expiries b...
- IPO investors brace for 73 lock-in expiries worth $34 billion in three months. Will your portfolio be impacted?India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...
- IPO investors brace for 83 lock-in expiries worth $55 billion in three months. Do you own any?IPO investors are bracing for a significant wave of lock-in expiries between May and August, with shares of 83 newly-listed companies value...
- India to attract major share of EQT's $15.6-billion Asia fund: EQT India headEQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...
- Gaudium IVF shares list at 5% premium over IPO price on BSE, NSEGaudium IVF and Women Health listed at a 5% premium over its IPO price, despite a flat GMP. The IPO saw strong retail and NII demand, and p...
- Gaudium IVF IPO Day 3: Subscribed over 4 times, check GMP trend, broker views and key detailsGaudium IVF's Rs 165 crore IPO saw strong demand, subscribed 4.09 times by its final day, driven by Non-Institutional and Retail Investors....
- Gaudium IVF IPO Day 2: 1.5x subscription, GMP trends, broker insights, and key highlightsGaudium IVF's IPO is seeing strong demand, with retail and non-institutional investors driving subscriptions to 1.5 times the offer size on...
- Gaudium IVF IPO Day 1: Subscribes 40%, GMP, brokerage views, and key detailsGaudium IVF and Women Health IPO opened with nearly 40% subscription on Day 1, driven by strong retail demand. GMP संकेत moderate listing g...
- Gaudium IVF IPO opens for bidding: Check brokerage reviews, GMP, price band and other detailsGaudium IVF's Rs 165 crore IPO opened on February 20, with analysts recommending subscription despite a moderate grey market premium. The c...
- IPO Calendar: Gaudium IVF to open next week as Fractal, Aye Finance head for listingThe key mainboard issue to watch will be Gaudium IVF & Women Health, which will open for subscription on February 20 and close on February ...
- Why are so many Indian hospitals rushing to the market?India's healthcare sector is poised for a significant IPO boom in 2026, with hospitals and allied services expected to raise Rs 20,000 cror...
- Hospitals, IVF chains fuel surge in healthcare IPOs worth Rs 20,000 croreIndia's primary market anticipates a significant influx of healthcare IPOs next year, with an estimated ₹20,000 crore in public issues expe...
- Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 monthsIndian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...
- Indira IVF IPO: EQT-backed fertility clinic chain refiles draft papers with Sebi via confidential routeFertility chain Indira IVF has refiled its Draft Red Herring Prospectus (DRHP) through the confidential filing route, reviving its public l...
- Indira IVF said to revive IPO plan that may raise Rs 3,500 croreIndira IVF Hospital is planning to launch its initial public offering in India. The company will soon submit preliminary documents for list...
- 20,000 babies a year, but are the records right? IVF system under fire in AustraliaAn Australian sperm donor, Mark, received incorrect family lists from his IVF clinic. The clinic wrongly identified him as the father of se...
- Trump signs executive order seeking to expand IVF accessPresident Donald Trump signed an executive order to increase access to in vitro fertilization (IVF) and reduce costs, directing a list of p...
- Syngene gets FIPB nod to raise foreign investment to 44%Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per...
Load More
